New funding opportunity for functional genomics platforms to resolve multiple VUS in priority genes for Australian diagnostic laboratories and clinicians.
Projects will be eligible for catalyst funding up to $200,000.
For many disease genes there are significant numbers of potentially disease-causing variants which do not reach the current threshold for definitive genetic diagnosis. This can be burdensome for variant interpretation and clinical reporting, particularly for rare disease.
The Australian Functional Genomics Network (AFGN) invites expressions of interest from Australian researchers from a second round of funding to establish platforms that will resolve multiple variants of uncertain significance (VUS) in priority genes.
A list of 22 high priority genes have been identified by Australian diagnostic laboratories and clinicians.
AFGN encourages researchers to utilise existing capabilities in their project design.
